3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
22
Phase 1/2
8
Phase 1
4
Phase NA
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Endocrine
9
Gastrointestinal
3
NET
2
Thoracic
1
Dermatologic
1
CNS
1
Conditions
Neuroendocrine Tumors
50
Pancreatic Neoplasms
6
Gastrointestinal Neoplasms
6
Stomach Neoplasms
5
Carcinoma, Hepatocellular
5
Colorectal Neoplasms
4
Rectal Neuroendocrine Tumor
3
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Liver Neoplasms
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Thyroid Neoplasms
2
Rectal Neoplasms
2
Neoplasms
2
Gastrointestinal Stromal Tumors
2
Gastro-enteropancreatic neuroendocrine tumor
2
Colonic Neoplasms
2
Carcinoma, Neuroendocrine
2
Carcinoma
2
Carcinoid Tumor
2
Biliary Tract Neoplasms
2
Appendiceal Neoplasms
2
Anus Neoplasms
2
Visceral Pain
1
Serotonin Syndrome
1
Recurrence
1
Rectal Neuroendocrine Tumors
1
Pheochromocytoma
1
Patients With Gastroenteropancreatic Neuroendocrine Tumors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Carcinoma, Neuroendocrine
×
NET
×
Clear all
NCT07377487
2026-05-22
INDIGO
Boston Scientific Corporation
Phase NA
Recruiting
51 enrolled
NCT03834701
2024-02-13
RAPNEN
Catholic University of the Sacred Heart
Phase NA
Completed
60 enrolled